Redeye provides an update following Optomed’s Q2 2025 report.
Suominen's Q2 report fell clearly short of Vara Research consensus expectations owing to very weak v...
Prospekterings- och gruvutvecklingsbolaget Bluelake Mineral fick planförslag och reguleringsplan för...
Rottneros reports SEK 140m impairment ahead of Q2 Challenging markets for Rottneros and Arctic Paper...
Adj. EBIT -29% vs FactSet consensus; FX adj sales -11% y-o-y Estimates to come down 8-10% on slower ...
Suominen Q2 comparable EBITDA of EUR 3.2m came clearly below Vara Research consensus expectation of ...
Redeye notes that BeammWave’s Q2 2025 report delivered a surprise, with the company posting net sale...
DT’s Q2 revenue was slightly higher than expected, however the EUR 1.
Etteplan’s H1 was disappointing, with the escalation of the trade war causing demand to weaken furth...
CapMan’s Q2 fee income of EUR 13.9m declined -7% y/y and was fairly in line with our estimate of EUR...
Redeye updates on EG7 ahead of Q2-results (due 15 August) where we expect solid YoY growth driven by...
Redeye updates on Embracer ahead of Q1-results (due 14 August) where we forecast a slow start to 202...
New full year guidance for adjusted EBITDA in core businesses’ is EUR 16–20m in 2025 (previously EUR...
Avtech has announced a three-year extension to its agreement with Wizz Air, significantly expanding ...
Redeye comments on Faron’s updated data from the Phase I/II BEXMAB trial in frontline high-risk MDS,...
SRV reports its Q2 figures on 8th of August. We continue to expect volume decline for the quarter, a...
Raute reports Q2 results on Aug 12. This year will set another earnings record, while the focus now ...
Redeye updates its estimates following Freemelt’s Q2 report, which was a record quarter, both in ter...
We expect a solid Q2 and raise '25e-'26e EBIT by 1% '25e-'28e EBIT CAGR of 31% driven by senior subs...
NoHo Partners' Q2 2025 results fell short of Vara Research consensus expectations, mainly due to the...
